MX2009013009A - Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico. - Google Patents

Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.

Info

Publication number
MX2009013009A
MX2009013009A MX2009013009A MX2009013009A MX2009013009A MX 2009013009 A MX2009013009 A MX 2009013009A MX 2009013009 A MX2009013009 A MX 2009013009A MX 2009013009 A MX2009013009 A MX 2009013009A MX 2009013009 A MX2009013009 A MX 2009013009A
Authority
MX
Mexico
Prior art keywords
immunoassays
kits
peptides
proteins
determination
Prior art date
Application number
MX2009013009A
Other languages
English (en)
Inventor
J Manuel Sarasa Barrio
Original Assignee
Araclon Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009013009(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech Sl filed Critical Araclon Biotech Sl
Publication of MX2009013009A publication Critical patent/MX2009013009A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La invención se relaciona con inmunoensayos que permiten la detección de polipéptidos en una muestra con una mayor sensibilidad que los ensayos conocidos en el estado de la técnica. La invención también se relaciona con kits que proporcionan los componentes necesarios para llevar a cabo dichos inmunoensayos.
MX2009013009A 2007-08-02 2007-12-05 Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico. MX2009013009A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (en) 2007-08-02 2007-08-02 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
MX2009013009A true MX2009013009A (es) 2010-03-29

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013009A MX2009013009A (es) 2007-08-02 2007-12-05 Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.

Country Status (23)

Country Link
US (2) US20090035790A1 (es)
EP (2) EP2020602A1 (es)
JP (1) JP5657382B2 (es)
KR (1) KR101461538B1 (es)
CN (1) CN101861521B (es)
AR (1) AR064186A1 (es)
AT (1) ATE533059T1 (es)
AU (1) AU2007357025B2 (es)
BR (1) BRPI0721871A2 (es)
CA (1) CA2689024C (es)
CL (1) CL2007003513A1 (es)
CY (1) CY1112553T1 (es)
DK (1) DK2183599T3 (es)
ES (1) ES2377151T3 (es)
HR (1) HRP20120020T1 (es)
IL (1) IL202598A (es)
MX (1) MX2009013009A (es)
PL (1) PL2183599T3 (es)
PT (1) PT2183599E (es)
RS (1) RS52124B (es)
RU (1) RU2461837C2 (es)
SI (1) SI2183599T1 (es)
WO (1) WO2009015696A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG179095A1 (en) 2009-09-18 2012-04-27 Probiodrug Ag Novel assay for the detection of amyloid beta peptides
WO2011070174A1 (en) * 2009-12-11 2011-06-16 Araclon Biotech, S.L. Methods and reagents for improved detection of amyloid beta peptides
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
WO2012015219A2 (en) * 2010-07-26 2012-02-02 Snu R&Db Foundation Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (en) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antibody, kit and method for determination of amyloid peptides
CN103827671B (zh) * 2011-05-03 2017-05-03 联邦科学与工业研究组织 用于检测神经疾病的方法
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
CN111770935A (zh) * 2018-02-27 2020-10-13 株式会社岛津制作所 特异性识别APP669-x的N末端的抗体及免疫测定法
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
DK1095278T3 (da) * 1998-07-03 2006-04-18 Innogenetics Nv Differentialdiagnose af neurodegeneration
WO2002002769A1 (en) * 2000-07-06 2002-01-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel app mutation associated with an unusual alzheimer's disease pathology
EP1371986A1 (en) * 2002-06-06 2003-12-17 ABETA GmbH Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio
PE20050627A1 (es) * 2003-05-30 2005-08-10 Wyeth Corp Anticuerpos humanizados que reconocen el peptido beta amiloideo
KR20080005260A (ko) * 2005-05-05 2008-01-10 머크 앤드 캄파니 인코포레이티드 알츠하이머 질환의 예방 및 치료를 위한 펩티드 접합체조성물 및 방법

Also Published As

Publication number Publication date
CY1112553T1 (el) 2016-02-10
PT2183599E (pt) 2012-02-13
EP2183599B1 (en) 2011-11-09
RU2009143671A (ru) 2011-05-27
ATE533059T1 (de) 2011-11-15
SI2183599T1 (sl) 2012-03-30
ES2377151T3 (es) 2012-03-22
AR064186A1 (es) 2009-03-18
CN101861521B (zh) 2014-03-12
EP2183599A1 (en) 2010-05-12
JP2010535328A (ja) 2010-11-18
US20090035790A1 (en) 2009-02-05
KR20100046168A (ko) 2010-05-06
AU2007357025A1 (en) 2009-02-05
US20190178899A1 (en) 2019-06-13
PL2183599T3 (pl) 2012-04-30
CA2689024A1 (en) 2009-02-05
HRP20120020T1 (hr) 2012-03-31
JP5657382B2 (ja) 2015-01-21
CL2007003513A1 (es) 2009-02-06
WO2009015696A1 (en) 2009-02-05
AU2007357025B2 (en) 2014-10-23
CA2689024C (en) 2015-02-24
IL202598A0 (en) 2010-06-30
DK2183599T3 (da) 2012-02-27
CN101861521A (zh) 2010-10-13
KR101461538B1 (ko) 2014-11-14
EP2020602A1 (en) 2009-02-04
BRPI0721871A2 (pt) 2014-02-18
RS52124B (en) 2012-08-31
IL202598A (en) 2015-10-29
RU2461837C2 (ru) 2012-09-20

Similar Documents

Publication Publication Date Title
MX2009013009A (es) Inmunoensayos de alta sensibilidad y kits para la determinacion de peptidos y proteinas de interes biologico.
CA2844033C (en) Method for detecting pancreatic cancer
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
ATE529752T1 (de) Antikörperquantifizierung
TR201818881T4 (tr) Sinyal Amplifikasyonu İmmünodeneyleri
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
MX2007010349A (es) Composiciones y metodos para clasificar muestras biologicas.
GB2490404B (en) Methods for determining ligand binding to a target protein using a thermal shift assay
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2008117067A3 (en) Protein signature/markers for the detection of adenocarcinoma
MX346499B (es) Dispositivos, metodos y kits de inmunocromatografia.
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
WO2009143098A3 (en) Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
WO2007082757A3 (en) Test systems for the analysis of polypeptides and cells adhering to silicones
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2006096697A3 (en) Methods for determining the bivalency of protein and antibody therapeutics
GB201113814D0 (en) Materials and methods for determining sensitivity potential of compounds
MX2010003707A (es) Nuevo proceso para separar y determinar la carga viral en una muestra de pancreatina.
PL1991875T3 (pl) Test do wykrywania patologicznych prionów
WO2010006183A3 (en) Measuring lipoprotein containing particles
GB0718603D0 (en) Methods
SE0401854D0 (sv) Method and kit for peptide analysis
WO2009108803A3 (en) Methods and compositions for immunoassays
GB0501564D0 (en) Test for prion disease

Legal Events

Date Code Title Description
FG Grant or registration